Magic mushroom chemical psilocybin on fast track to become FDA-approved treatment for depression
Psilocybin, the working chemical in magic mushrooms, has shown promise for treating stubborn, severe depression in early clinical trials
Psilocybin, the "magic musghroom" chemical, has come a step closer to becoming a legal treatment for difficult cases of depression after the Food & Drug Administration (FDA) gave its "Breakthrough Therapy" designation to a psychedelic-based treatment of a UK-based company.
This week, Compass Pathways announced the designation, which it says will fast track the FDA’s review of the treatment for possible approval. The FDA approved a trial of the chemical in the US for this first time in August this year, Daily Mail reports.